Comparative Pharmacology
Head-to-head clinical analysis: PSEUDOEPHEDRINE HYDROCHLORIDE versus WYAMINE SULFATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PSEUDOEPHEDRINE HYDROCHLORIDE versus WYAMINE SULFATE.
PSEUDOEPHEDRINE HYDROCHLORIDE vs WYAMINE SULFATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Pseudoephedrine is a sympathomimetic amine that acts as a decongestant by stimulating alpha-adrenergic receptors in the respiratory tract mucosa, causing vasoconstriction and reducing nasal congestion. It also has weak beta-adrenergic activity.
Wyamine sulfate (mephentermine sulfate) is a sympathomimetic amine that acts primarily by releasing norepinephrine from presynaptic nerve terminals, with direct alpha- and beta-adrenergic receptor agonist activity. It causes vasoconstriction and positive inotropic effects, increasing cardiac output and blood pressure.
60 mg orally every 4 to 6 hours as needed; maximum 240 mg per day.
Intramuscular injection: 15-30 mg as a single dose; may repeat in 10-15 minutes if needed. Maximum total dose: 60 mg.
None Documented
None Documented
Terminal elimination half-life: 5-8 hours in adults with normal renal function, prolonged in renal impairment (up to 16-20 hours in severe impairment)
Terminal elimination half-life is 6-8 hours in adults with normal renal function (CrCl >90 mL/min).
Renal: 70-90% unchanged via glomerular filtration and tubular secretion; fecal: <1%; biliary: minimal
Primarily renal; 90% excreted unchanged in urine within 24 hours. Minimal biliary/fecal elimination (<5%).
Category A/B
Category C
Sympathomimetic
Sympathomimetic